By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ferring Pharmaceuticals 

Avenue de Rhodanie 60

Lausanne    CH 1007  Switzerland
Phone: 41-21-614-2772 Fax: 41-21-614-2773



Company News
Ferring Pharma Partners With Intralytix To Develop Bacteriophage Treatments For Conditions Associated With The Microbiome And Drug-Resistant Bacteria 1/9/2017 10:51:00 AM
Ferring Pharma And IMAB Sign Licensing Agreement Granting IMAB Exclusive Rights In Asia To Olamkicept For The Treatment Of Autoimmune Disease 12/19/2016 10:22:19 AM
Ferring Pharma Receives EU Approval For REKOVELLE (Follitropin Delta) 12/13/2016 10:37:20 AM
BioGaia Associated Metabogen Starts Study On Intrahepatic Cholestasis Of Pregnancy With Ferring Pharma 12/7/2016 9:36:43 AM
Ferring Pharma Collaborates With Metabogen AB On Development Of Microbiome-Based Treatment For Intrahepatic Cholestasis Of Pregnancy (ICP) 12/5/2016 1:32:51 PM
Levo Therapeutics To License Exclusive Rights To Ferring Pharma' Orphan-Designated Drug, Carbetocin, For The Treatment Of Prader-Willi Syndrome 10/28/2016 7:29:59 AM
Ferring Pharma Receives Positive CHMP Opinion For REKOVELLE (Follitropin Delta) 10/17/2016 1:13:04 PM
Apricus Biosciences (APRI) Announces Completion Of Transfer Of The Marketing Authorizations For Vitaros® In Finland And Denmark To Ferring Pharma 9/20/2016 8:01:49 AM
Ferring Pharma Recognized As The Nation’s Most Adoption-Friendly Workplace By Dave Thomas Foundation For Adoption 9/14/2016 11:29:29 AM
Ferring Pharma And North Zealand University Hospital Mark First Milestone In Innovative IBD Collaboration 8/31/2016 11:32:50 AM